Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conferenceseries: World’s leading Event Organizer

Conference Series Conferences gaining more Readers and Visitors

Conference Series Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Yuanpeng Janet Huang

Yuanpeng Janet Huang

Rutgers University USA

Sevgi Gezici

Sevgi Gezici

Texas A&M University USA

John Wilson

John Wilson

Cold Spring Harbor Laboratory USA

Steven Pelech

Steven Pelech

Kinexus Bioinformatics Corporation Canada

Uma Shankavaram

Uma Shankavaram

National Institutes of Health USA

Xusheng Wang

Xusheng Wang

St Jude Childrens Research Hospital USA

Hesham H. Ali

Hesham H. Ali

University of Nebraska USA

Alexander Statsyuk

Alexander Statsyuk

Northwestern University USA

Proteomics Congress 2018

About Conference


Conference Series Ltd like to take this opportunity to welcome all of you to “12th International Conference & Expo on Proteomics and Molecular Medicine” which is to be held during November 26-28, 2018 at Dublin, Ireland. Through our theme ‘Solving problems in Proteomics, Biology and Medicine’, the conference will analyze the recent advancements and new modes that can be enforced to the research to take proteomics and molecular medicine, one step further.

Proteomics Congress 2018 conference will impact an attractive moment to meet people in the research field and therefore it takes a delight in opening a gate to meet the ability in the field, young researchers and potential speakers. The conference also includes essential topics on Protein Expression and Analysis, Proteomics and Molecular MedicineProteomics Database, Mass Spectrometry in Proteome Research, Proteomics from Discovery to Function, Analytical Proteomics and Genomics, Protein Biochemistry and Proteomics, Proteomics in Personalized Medicine, Cardiovascular Proteomics, Proteomics in Computational and Systems Biology, Proteomics for Bioinformatics, Plant Proteomics and Applications, Food and Nutritional Proteomics, Cancer and Clinical proteomics, Immunoproteomics, Protein Engineering and Molecular Design, Neuroproteomics & Neurometabolomics and many more. 

Conference Series Ltd coordinates 1000+ Global events. Every Year across USA, Europe and Asia with backing from 1000 more scientific societies & Publishes 700+ Open access journals which encompass over 100000 eminent personalities, reputed scientists as an editorial board & organizing committee members. Conference Series Ltd is recognized by International Congress as well as Convention Association. World Congress and also International conference as momentously captivated by Nobel laureates, International Symposiums & Workshops, Keynote gatherings, Exhibitions and Delegates.

Hence, we welcome you all to be a part of this event to contribute your novel research ideas.

‚ÄčThe European Union (EU) has become a popular hub for advanced research into proteomics as well as molecular medicine. This can be attributed to the significant government funding at both the national level and from individual EU agencies. Global market for Proteomics is forecast to exceed $15 billion by 2020, buoyed by growing demand for personalized medicine, and strong R&D investments in proteomics-based drug discovery projects and which is fueled by the importance of accurate and sensitive diagnosis offered by proteomics in the area of personalized medicine, the market for proteomics is expected to register strong growth in the coming years.

The molecular diagnostics technologies that will play an important role in practice of medicine, public health, pharmaceutical industry, forensics and biological warfare in the 21st century. This includes several polymerase chain reaction (PCR)-based technologies, fluorescent in situ hybridization (FISH), peptide nucleic acids (PNA), electrochemical detection of DNA, sequencing, mitochondrial DNA, biochips, nanotechnology and proteomic technologies.

Proteomics is a developing field that has been deeply enabled by the human genome project. Proteins are also the products of genes, the machinery of the cells within our bodies. When genes are disturbed, the proteins are also effected. When pathogens infect, causing disease these proteins play a major role in signaling the presence & ridding us of these invaders. Almost in each and every process that occurs in our cells from the metabolization of simple sugar to the distribution of cells is dependent on proteins for smooth operation. In general, proteomics seeks to disclose and quantify as many proteins as possible.

Sessions/Tracks

ConferenceSeries Ltd would like to take this privilege to invite you all to the “12th International Conference and Expo on Proteomics and Molecular Medicine” that is to be held during November 26-28, 2018 at Dublin, Ireland. Through our theme ‘Solving problems in Proteomics, Biology and Medicine’, the conference will explore the recent advancements and new methodologies that can be applied to the research to take proteomics and molecular medicine, one step further.

The broad subject coverage of the Congress and its size provide an excellent setting for participants to gain valuable insight into progress in research areas beyond their own. In addition, a range of special sessions aim to engage participants on wider issues, such as teaching in the proteomics research.

The Proteomics Congress has a strong emphasis on support and inspiration for the next generation of scientists, along with early-career researchers, a Young Researchers Forum, and activities to encourage interaction with peers and experts.

Altogether the Congress aims to be an exemplary cross-discipline gathering in the proteomics life sciences for research presentation, discussion, learning, inspiration and encouragement with participants leaving with new research knowledge and ideas, and perhaps the beginnings of international collaborations and friendships.

Scientific Sessions:

Track: 1 Proteomics from Discovery to Function

Proteomics is an emerging field that has been highly enabled by the human genome project. Proteins are the products of genes, the machinery of the cells in our bodies. When genes are disrupted, the proteins are also affected. When pathogens infect us, causing disease, proteins play a key role in signaling the presence and ridding us of these invaders. Almost every process that occurs in our cells – from the metabolization of simple sugar to the division of cells – is dependent on proteins for smooth operation. In general, proteomics seeks to detect and quantify as many proteins as possible.

Relevant Conferences:

3rd International Conference on Enzymology and Molecular Biology, March 05-06, 2018 London, UK; 13th International Conference on Metabolomics and Systems Biology, June 11-12, 2018 London, UK; 13th International Conference on Structural Biology, July 13-14, 2018 Toronto, Canada; 5th International Conference on Glycobiology, Lipids & Proteomics, August 27-28, 2018 Toronto, Canada; 3rd International Conference on Molecular Biology & Nucleic Acids, August 27-28, 2018 Toronto, Canada; 23rd Annual Lorne Proteomics Symposium, February 01-04, 2018, Victoria, Australia; The Molecular Medicine Tri Conference, February 11-16, 2018, San Francisco, California; The 66th Annual Conference on Mass Spectrometry, May 15-18, 2018, Osaka, Japan; XXII International Mass Spectrometry Conference, August 26-31, 2018, Florence, Italy; HUPO 2018, September 30-October 03, 2018 Florida, USA

Track: 2 Mass Spectrometry in Proteome Research

Mass spectrometry (MS) - based proteomics allows the sensitive and accurate quantification of almost complete proteomes of complex biological fluids and tissues. At the moment, however, the routinely usage of MS-based proteomics is prevented and complicated by the very complex work flow comprising sample preparation, chromatography, MS measurement followed by data processing and evaluation. The new technologies, products and assays developed by Precision Proteomics could help enabling and establishing mass spectrometry (MS) - based proteomics in academic and pharmaceutical proteomics research as well as in clinical diagnostics.

Relevant Conferences:

3rd International Conference on Enzymology and Molecular Biology, March 05-06, 2018 London, UK; 13th International Conference on Metabolomics and Systems Biology, June 11-12, 2018 London, UK; 13th International Conference on Structural Biology, July 13-14, 2018 Toronto, Canada; 5th International Conference on Glycobiology, Lipids & Proteomics, August 27-28, 2018 Toronto, Canada; 3rd International Conference on Molecular Biology & Nucleic Acids, August 27-28, 2018 Toronto, Canada; 23rd Annual Lorne Proteomics Symposium, February 01-04, 2018, Victoria, Australia; The Molecular Medicine Tri Conference, February 11-16, 2018, San Francisco, California; The 66th Annual Conference on Mass Spectrometry, May 15-18, 2018, Osaka, Japan; XXII International Mass Spectrometry Conference, August 26-31, 2018, Florence, Italy; HUPO 2018, September 30-October 03, 2018 Florida, USA

Track: 3 Proteomics and Molecular Medicine

Molecular Medicine promotes the thoughtful of biological mechanism of disease at the cellular and molecular levels for enhanced diagnoses, treatment, and prevention of disease. Proteomics plays an important role in medical research and molecular medicine, such as in drug discovery and diagnostics, because of the link between proteins, genes and diseases, and it is considered to be the next step in modern biology. Proteomics is dynamic compared to genomics because it changes constantly to reflect the cell’s environment. The main objectives in the arena of proteomics are; identifying all proteins, analyse differential protein expression in different samples, characterise proteins by identifying and studying their function and cellular localisation, and recognize protein interaction networks.

Relevant Conferences:

3rd International Conference on Enzymology and Molecular Biology, March 05-06, 2018 London, UK; 13th International Conference on Metabolomics and Systems Biology, June 11-12, 2018 London, UK; 13th International Conference on Structural Biology, July 13-14, 2018 Toronto, Canada; 5th International Conference on Glycobiology, Lipids & Proteomics, August 27-28, 2018 Toronto, Canada; 3rd International Conference on Molecular Biology & Nucleic Acids, August 27-28, 2018 Toronto, Canada; 23rd Annual Lorne Proteomics Symposium, February 01-04, 2018, Victoria, Australia; The Molecular Medicine Tri Conference, February 11-16, 2018, San Francisco, California; The 66th Annual Conference on Mass Spectrometry, May 15-18, 2018, Osaka, Japan; XXII International Mass Spectrometry Conference, August 26-31, 2018, Florence, Italy; HUPO 2018, September 30-October 03, 2018 Florida, USA

Track: 4 Molecular Medicine and Diagnostics

Molecular diagnostics is prominent disruptive innovation in healthcare by the introduction of many tools that are having a profound impact on healthcare delivery. These include next-generation sequencing, wearable sensors, liquid biopsies, direct-to-consumer testing, point-of-care assays, and early cancer detection. Join industry leaders at the molecular diagnostics event to discuss recent developments and decipher how changes in regulation, reimbursement, and implementation guidelines will impact progress in new markets created by innovations in this technology.

Relevant Conferences:

3rd International Conference on Enzymology and Molecular Biology, March 05-06, 2018 London, UK; 13th International Conference on Metabolomics and Systems Biology, June 11-12, 2018 London, UK; 13th International Conference on Structural Biology, July 13-14, 2018 Toronto, Canada; 5th International Conference on Glycobiology, Lipids & Proteomics, August 27-28, 2018 Toronto, Canada; 3rd International Conference on Molecular Biology & Nucleic Acids, August 27-28, 2018 Toronto, Canada; 23rd Annual Lorne Proteomics Symposium, February 01-04, 2018, Victoria, Australia; The Molecular Medicine Tri Conference, February 11-16, 2018, San Francisco, California; The 66th Annual Conference on Mass Spectrometry, May 15-18, 2018, Osaka, Japan; XXII International Mass Spectrometry Conference, August 26-31, 2018, Florence, Italy; HUPO 2018, September 30-October 03, 2018 Florida, USA

Track: 5 Molecular Diagnostics and Devices

Molecular diagnostics and devices are enabling precise diagnosis and treatment of oncology, infectious disease and immunotherapy. Experts in the arena will highlight the latest tools, clinical advances, besides commercial applications of circulating and tissue-based biomarkers that are transforming medicine.

Relevant Conferences:

3rd International Conference on Enzymology and Molecular Biology, March 05-06, 2018 London, UK; 13th International Conference on Metabolomics and Systems Biology, June 11-12, 2018 London, UK; 13th International Conference on Structural Biology, July 13-14, 2018 Toronto, Canada; 5th International Conference on Glycobiology, Lipids & Proteomics, August 27-28, 2018 Toronto, Canada; 3rd International Conference on Molecular Biology & Nucleic Acids, August 27-28, 2018 Toronto, Canada; 23rd Annual Lorne Proteomics Symposium, February 01-04, 2018, Victoria, Australia; The Molecular Medicine Tri Conference, February 11-16, 2018, San Francisco, California; The 66th Annual Conference on Mass Spectrometry, May 15-18, 2018, Osaka, Japan; XXII International Mass Spectrometry Conference, August 26-31, 2018, Florence, Italy; HUPO 2018, September 30-October 03, 2018 Florida, USA

Track: 6 Protein Expression and Analysis

Protein expression refers to the way in which proteins are synthesized, modified and regulated in living organisms. In protein research, the term can apply to either the object of study or the laboratory techniques required to manufacture proteins. Protein analysis is the bioinformatics study of protein structure, protein interaction and function using database searches, sequence comparisons, structural and functional predictions.

Relevant Conferences:

3rd International Conference on Enzymology and Molecular Biology, March 05-06, 2018 London, UK; 13th International Conference on Metabolomics and Systems Biology, June 11-12, 2018 London, UK; 13th International Conference on Structural Biology, July 13-14, 2018 Toronto, Canada; 5th International Conference on Glycobiology, Lipids & Proteomics, August 27-28, 2018 Toronto, Canada; 3rd International Conference on Molecular Biology & Nucleic Acids, August 27-28, 2018 Toronto, Canada; 23rd Annual Lorne Proteomics Symposium, February 01-04, 2018, Victoria, Australia; The Molecular Medicine Tri Conference, February 11-16, 2018, San Francisco, California; The 66th Annual Conference on Mass Spectrometry, May 15-18, 2018, Osaka, Japan; XXII International Mass Spectrometry Conference, August 26-31, 2018, Florence, Italy; HUPO 2018, September 30-October 03, 2018 Florida, USA

Track: 7 Proteomics and its Medicinal Research

Personalised medicine aims to tailor treatments to achieve the best outcome for individual patients, rather than treating patients with a ‘one size fits all’ approach. Personalized medicine, also termed precision medicine, is a medical procedure that separates patients into different groups—with medical decisions, practices, interventions and/or products being tailored to the individual patient based on their predicted response or risk of disease.

Relevant Conferences:

3rd International Conference on Enzymology and Molecular Biology, March 05-06, 2018 London, UK; 13th International Conference on Metabolomics and Systems Biology, June 11-12, 2018 London, UK; 13th International Conference on Structural Biology, July 13-14, 2018 Toronto, Canada; 5th International Conference on Glycobiology, Lipids & Proteomics, August 27-28, 2018 Toronto, Canada; 3rd International Conference on Molecular Biology & Nucleic Acids, August 27-28, 2018 Toronto, Canada; 23rd Annual Lorne Proteomics Symposium, February 01-04, 2018, Victoria, Australia; The Molecular Medicine Tri Conference, February 11-16, 2018, San Francisco, California; The 66th Annual Conference on Mass Spectrometry, May 15-18, 2018, Osaka, Japan; XXII International Mass Spectrometry Conference, August 26-31, 2018, Florence, Italy; HUPO 2018, September 30-October 03, 2018 Florida, USA

Track: 8 Proteomics in Biochemistry and Molecular Biology

Biochemistry is the study of the structure and function of biological molecules such as proteins, nucleic acids, carbohydrates and lipids. Biochemistry is also used to describe techniques suited to understanding the interactions and functions of biological molecules and it is a laboratory based science that brings together biology and chemistry. By using chemical knowledge and techniques, biochemists can understand and solve biological problems. Biochemistry focuses on processes happening at a molecular level and it focuses on what’s happening inside our cells. It also looks at how cells communicate with each other, for example during growth or fighting illness. Medicine is a broad category but relates to biochemistry on many levels. Doctors and nurses give drugs to patients to help cure a disease or prevent it. This is since when that drug is added to the human system, it alters how other chemicals in the body function, resulting in disease prevention or recovery.

Relevant Conferences:

3rd International Conference on Enzymology and Molecular Biology, March 05-06, 2018 London, UK; 13th International Conference on Metabolomics and Systems Biology, June 11-12, 2018 London, UK; 13th International Conference on Structural Biology, July 13-14, 2018 Toronto, Canada; 5th International Conference on Glycobiology, Lipids & Proteomics, August 27-28, 2018 Toronto, Canada; 3rd International Conference on Molecular Biology & Nucleic Acids, August 27-28, 2018 Toronto, Canada; 23rd Annual Lorne Proteomics Symposium, February 01-04, 2018, Victoria, Australia; The Molecular Medicine Tri Conference, February 11-16, 2018, San Francisco, California; The 66th Annual Conference on Mass Spectrometry, May 15-18, 2018, Osaka, Japan; XXII International Mass Spectrometry Conference, August 26-31, 2018, Florence, Italy; HUPO 2018, September 30-October 03, 2018 Florida, USA

Track: 9 Precision Medicine and Immuno-Oncology

The significance and role of the human genome in the diagnosis and treatment of disease, they lay out the groundwork for precision or genomic medicine. In turn, immuno-oncology researches are changing the way we treat cancer by unleashing the immune system, and achieving better survival for many patients and cure for some. Covering latest advances in precision medicine, genomics and genetics for drug discovery application, cancer immuno-therapy, biomarkers and translational strategies in immune-oncology, Precision Medicine and Immuno-Oncology tracks will bring together uppermost experts from industry and academia to discuss emerging trends and solutions in order to provide the most up-to-date, scientifically sound care for patients with cancer and chronic diseases.

Relevant Conferences:

3rd International Conference on Enzymology and Molecular Biology, March 05-06, 2018 London, UK; 13th International Conference on Metabolomics and Systems Biology, June 11-12, 2018 London, UK; 13th International Conference on Structural Biology, July 13-14, 2018 Toronto, Canada; 5th International Conference on Glycobiology, Lipids & Proteomics, August 27-28, 2018 Toronto, Canada; 3rd International Conference on Molecular Biology & Nucleic Acids, August 27-28, 2018 Toronto, Canada; 23rd Annual Lorne Proteomics Symposium, February 01-04, 2018, Victoria, Australia; The Molecular Medicine Tri Conference, February 11-16, 2018, San Francisco, California; The 66th Annual Conference on Mass Spectrometry, May 15-18, 2018, Osaka, Japan; XXII International Mass Spectrometry Conference, August 26-31, 2018, Florence, Italy; HUPO 2018, September 30-October 03, 2018 Florida, USA

Track: 10 Proteomics in Computational Systems Biology

Systems biology is an exciting new approach to understand biological complexity. It builds on large-scale measurement technologies, such as next-generation sequencing and mass spectrometry.

Relevant Conferences:

3rd International Conference on Enzymology and Molecular Biology, March 05-06, 2018 London, UK; 13th International Conference on Metabolomics and Systems Biology, June 11-12, 2018 London, UK; 13th International Conference on Structural Biology, July 13-14, 2018 Toronto, Canada; 5th International Conference on Glycobiology, Lipids & Proteomics, August 27-28, 2018 Toronto, Canada; 3rd International Conference on Molecular Biology & Nucleic Acids, August 27-28, 2018 Toronto, Canada; 23rd Annual Lorne Proteomics Symposium, February 01-04, 2018, Victoria, Australia; The Molecular Medicine Tri Conference, February 11-16, 2018, San Francisco, California; The 66th Annual Conference on Mass Spectrometry, May 15-18, 2018, Osaka, Japan; XXII International Mass Spectrometry Conference, August 26-31, 2018, Florence, Italy; HUPO 2018, September 30-October 03, 2018 Florida, USA

Track: 11 Proteomics for Bioinformatics

Bioinformatics is both an umbrella term for the body of biological studies that use computer programming as part of their methodology, as well as a reference to specific analysis "pipelines" that are repeatedly used, particularly in the fields of genetics and genomics. Common uses of bioinformatics include the identification of candidate genes and nucleotides.

Relevant Conferences:

3rd International Conference on Enzymology and Molecular Biology, March 05-06, 2018 London, UK; 13th International Conference on Metabolomics and Systems Biology, June 11-12, 2018 London, UK; 13th International Conference on Structural Biology, July 13-14, 2018 Toronto, Canada; 5th International Conference on Glycobiology, Lipids & Proteomics, August 27-28, 2018 Toronto, Canada; 3rd International Conference on Molecular Biology & Nucleic Acids, August 27-28, 2018 Toronto, Canada; 23rd Annual Lorne Proteomics Symposium, February 01-04, 2018, Victoria, Australia; The Molecular Medicine Tri Conference, February 11-16, 2018, San Francisco, California; The 66th Annual Conference on Mass Spectrometry, May 15-18, 2018, Osaka, Japan; XXII International Mass Spectrometry Conference, August 26-31, 2018, Florence, Italy; HUPO 2018, September 30-October 03, 2018 Florida, USA

Track: 12 Proteomics and its Research

Proteins provide most of the molecular machinery of cells. Many are enzymes or subunits of enzymes. Other proteins play structural or mechanical roles, such as those that form the struts and joints of the cytoskeleton. Each protein is linear polymers built of amino acids.

Relevant Conferences:

3rd International Conference on Enzymology and Molecular Biology, March 05-06, 2018 London, UK; 13th International Conference on Metabolomics and Systems Biology, June 11-12, 2018 London, UK; 13th International Conference on Structural Biology, July 13-14, 2018 Toronto, Canada; 5th International Conference on Glycobiology, Lipids & Proteomics, August 27-28, 2018 Toronto, Canada; 3rd International Conference on Molecular Biology & Nucleic Acids, August 27-28, 2018 Toronto, Canada; 23rd Annual Lorne Proteomics Symposium, February 01-04, 2018, Victoria, Australia; The Molecular Medicine Tri Conference, February 11-16, 2018, San Francisco, California; The 66th Annual Conference on Mass Spectrometry, May 15-18, 2018, Osaka, Japan; XXII International Mass Spectrometry Conference, August 26-31, 2018, Florence, Italy; HUPO 2018, September 30-October 03, 2018 Florida, USA

Market Analysis

Summary:

Proteomics attribute to the study of proteomes, but is also used to characterize the techniques used to determine the complete set of proteins of an organism or system, such as protein purification and MS. Proteomics is a developing field that has been deeply enabled by the human genome project. Proteins which are the products of genes, the machinery of the cells in our bodies. When genes are disturbed, the proteins are also damaged. When pathogens infect us, causing disease, proteins play a major role in signaling the presence & ridding us of these invaders. Almost every process which that occurs in our cells from the metabolization of clean sugar to the distribution of cells is dependent on proteins for smooth operation. In general, proteomics seeks to distinguish & quantify as many proteins as possible likewise Molecular Medicine promotes the understanding of biological mechanism of disease at the cellular and molecular levels for better diagnoses, treatment, and prevention of disease. Proteomics plays an important role in medical research and molecular medicine, such as in drug discovery and diagnostics, because of the link between proteins, genes and diseases, and it is considered to be the next step in modern biology.

Importance & Scope:

There are numerous advances in this proteomics innovation, especially in the field of sub-atomic science. New proteomics and genomics advancements and creations could be utilized for ailment particular biomarker revelation and to screen tolerant reaction to the treatment. Proteomics might likewise set up new, atomic order of the malady. Applying genomic and proteomic strategies to body liquids (serum, cerebrospinal liquid, pee, and so on.) and tissue concentrates would put profitable goal diagnostic force in the hands of the clinician however approval of those techniques is an imperative issue. The quick extension of the analytic apparatuses taking into account advancements in proteomic and genomic advances can be essential for the improvement of customized solution. As a science that studies interactions between the molecular components that carry out the various biological processes in living cells, an important idea in molecular biology states that information flow in organisms follows a one-way street: Genes are transcribed into RNA, and RNA is translated into proteins.

Why Dublin, Ireland?

Europe is one such region which encompasses the major share of the Proteomics and molecular medicine research which is mainly on ovarian cancer biomarker research. Dublin being one of the most advanced European economies is bound to hold the chief share in Europe’s Proteomics and molecular medicine market. Further as EU expands the research, export and trading relations are bound to enhance.

Why to attend???

The global proteomics market is projected to reach USD 21.87 Billion by 2021, at a CAGR of 11.7% from 2016 to 2021. The global proteomics market exhibits potential for significant growth and is propelled by the increasing need for personalized medicine, R&D expenditure, technological advancements, and increased funding for proteomics projects and The global molecular diagnostics market size was valued at USD 6.45 billion in 2015. It is expected to witness attractive growth with a CAGR of around 12.0% till 2024. Molecular diagnostics are highly effective in diagnosing infectious diseases and performing preventive cancer screening thus helping healthcare professionals to prescribe accurate therapeutic interventions in the early stages of diseases. Increasing prevalence of hospital acquired infections and other communicable infections are anticipated to drive the sector expansion over the forecast period; it would be an awesome open door for organizations managing Analytical instruments valuable in these fields. Likewise numerous up and participating so as to come understudies and scientists can advantage themselves world class International workshops, symposia amid the gathering which will be directed by specialists in the particular fields.

Major Proteomics and Molecular Medicine, diagnostics Related Associations around the Globe:

  • Human Proteome Organization
  • European Proteomics Association (Eupa)
  • Spanish Proteomics Society– (Seprot)
  • Netherlands Proteomic Platform (Npp)
  • Japan Human Proteome Organisation (Jhupo)
  • Italian Proteomic Association (Itpa)
  • Portugese Proteomic Association (Rede Procura)
  • Iranian Proteomic Society
  • Taiwan Proteomic Society (Tps)
  • Austrian Proteomics Society
  • European Proteomics Association
  • British Mass Spectrometry Society
  • Belgian Mass Spectrometry Society
  • Danish Mass Spectrometry Society
  • Australian and New Zealand Mass Spectrometry Society
  • Indiana Proteomics Consortium
  • Proteome Society
  • European federation of biotechnology
  • Australasian Proteomics Society
  • Association for Molecular Pathology
  • Molecular and Cellular Cognition Society
  • Hong Kong Society For Molecular Diagnostic Sciences Limited
  • Biochemical Society
  • Society for Molecular Biology & Evolution
  • The French Society for Biochemistry and Molecular Biology
  • The German Society for Biochemistry and Molecular Biology

Target Audience: 

Meet leading proteomicists, proteomics researchers, pharmaceutical leaders, scientists, bioinformaticians, physicians, doctors, health care professionals, molecular diagnosticians, clinicians, researchers, Executives/Managers and Business Delegates, Director of Laboratories, Universities, Industries, Investigators, Post-Doctoral Fellows, Research & Diagnostic Laboratories, Clinical Fellows, Students, Biomedical Research organizations, societies and associations.

Proteomics and Molecular Medicine, Diagnostics Market Projection:

The global proteomics market is expected to reach over USD 24.8 billion by 2024 according to a new report by Grand View Research, Inc. The introduction of technology-enabled proteomics products is one of the high-impact rendering drivers for the proteomics market growth. These products find extensive applications in drug discovery, diagnostic services, and many other research areas. The increasing market penetration of these technologies, such as ESI-LC-MS (electrospray ionization liquid chromatography mass spectrometry), is expected to serve as a driver of this market.

Proteomics Market By Product, USD Million, 2013 - 2024

The europe molecular diagnostics market is expected to reach USD4.0 billion by 2024, according to a new report by Grand View Research, Inc. Growing geriatric population and the increasing prevalence of neurological and cardiovascular disorders is expected to drive the growth of molecular diagnostics. Moreover, increasing demand for more efficient healthcare delivery to facilitate early diagnostics is further expected to boost market growth. 

Molecular medicine, diagnostic market by application, 2013-2024 USD Million

Past Conference Report

Proteomics Congress 2017

Conference Series Ltd takes a great pride in announcing the “9th International Conference & Expo on Proteomics and Molecular Medicine” (Proteomics Congress 2017) which was held in Paris, France, during 13-15 November, 2017.

Proteomics Congress 2017 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various newfangled topics related to the field of proteomics and molecular medicine. The extremely illustrious conference hosted by Conference Series Ltd was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 30 countries around the world.

The conference aimed a parallel rail with theme “Novel Advancements in Proteomics and Molecular Medicine”. The meeting engrossed a vicinity of cognizant discussions on novel subjects like Mass spectrometry in Proteome Research, Protein Expression and Analysis, Proteomics from Discovery to Function, Molecular Medicine and Diagnostics, to mention a few. The three days event implanted a firm relation of upcoming strategies in the field of Proteomics, Molecular Medicine, Bioinformatics and Mass Spectrometry Technology with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

The Organizing Committee would like to thank the moderators Dr. Oliva Petra from Sanofi Genzyme, USA, Dr. Marwa Eltoweissy, University of Göttingen, Germany for their contributions which resulted in smooth functioning of the conference.

The conference was embarked with an opening ceremony followed by a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The highlights of the conference were the keynote forum by prominent scientists, Boris Zaslavsky, Cleveland Diagnostics, USA; Bin Huang, Kaohsiung Medical University, Taiwan; Judit Ovádi, Hungarian Academy of Sciences, Hungary; Jarrod A Marto, Harvard Medical School, USA; Magnus S Magnusson, University of Iceland, Iceland; gave their fruitful contributions in the form of highly informative presentations and made the conference a top notch one.

Conference Series Ltd is prerogative to thank the Organizing Committee Members, Keynote speakers, Chair and Co-chairs on transcribing the plenary sessions, workshops and special sessions in a diversified and variegate manner to make this conference an enviable artifact.

Conference Series Ltd offers its heartfelt appreciation to the exhibitor Proteintech, collaborators Instruct Integrating Biology, European Biotechnology Network, Bilkent Genetik Toplulugu, Malaysian Biotechnology Information Center, Swiss Biotech Association & Human Behaviour Laboratory who supported the conference in every aspect for the awe-inspiring exhibition at the venue. We also express our sincere thanks to all the media partners for the promotion of our event to glory.

Conference Series Ltd congratulates the best poster award winner Dr. Pratibha Sharma, All India Institute of Medical Sciences, India. We would also like to thank Dr. Jarrod A Marto, Harvard Medical School, USA and Dr. Pavlina Dolashka, Bulgarian Academy of Sciences, Bulgaria who supported us by evaluating the posters.

We once again thank all the participants for their wonderful contribution towards the event which helped us for successful accomplishment of this event.

Conference Series Ltd 9th International Conference & Expo on Proteomics and Molecular Medicine would not have been successful if it has not been supported by international, multi-professional steering committee and coordination of the Journal of Proteomics & Bioinformatics, Journal of Pharmacogenomics & Pharmacoproteomics & Journal of Data Mining in Genomics & Proteomics.

After the successful completion of eleven consecutive conferences we are overwhelmed to announce our next upcoming conferences which are going to be held in Europe is the “12th International Conference and Expo on Proteomics and Molecular Medicine” which is going to be held during November 26-28, 2018 in Dublin, Ireland.


Past Reports  Proceedings  Gallery  

Proteomics Congress 2016

Conference Series LLC takes a great pride in announcing the “7th International Conference & Expo on Proteomics (Proteomics Congress 2016) which was held in Rome, Italy, during 24-26 October, 2016.

Proteomics Congress 2016 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various newfangled topics related to the field of proteomics. The extremely illustrious conference hosted by Conference Series LLC was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 25 countries around the world.

The conference aimed a parallel rail with theme “Proteomics: An atlas of expression”. The meeting engrossed a vicinity of cognizant discussions on novel subjects like Proteomics from Discovery to Function, Mass Spectrometry in Proteome Research, Proteomics for Bioinformatics, Cancer and Clinical proteomics, to mention a few. The three days event implanted a firm relation of upcoming strategies in the field of Proteomics, Bioinformatics and Mass Spectrometry Technology with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

The Organizing Committee would like to thank the moderators Dr. Marwa Eltoweissy, University of Göttingen, Germany, Dr. Jill Barber, University of Manchester, UK for their contributions which resulted in smooth functioning of the conference.

The conference was embarked with an opening ceremony followed by a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The highlights of the conference were the keynote forum by prominent scientists, Boris Zaslavsky, Cleveland Diagnostics, USA; John F Cipollo, Center for Biologics Evaluation and Research-USFDA, USA; Stefan Kempa, Berlin Institute for Medical Systems Biology - MDC Berlin, Germany; Magnus S Magnusson, University of Iceland, Iceland; gave their fruitful contributions in the form of highly informative presentations and made the conference a top notch one.

Conference Series LLC is prerogative to thank the Organizing Committee Members, Keynote speakers, Chair and Co-chairs on transcribing the plenary sessions, workshops and special sessions in a diversified and variegate manner to make this conference an enviable artifact.

Conference Series LLC offers its heartfelt appreciation to the exhibitor Leica Microsystems, collaborators MABIC & Human Behaviour Laboratory who supported the conference in every aspect for the awe-inspiring exhibition at the venue. We also express our sincere thanks to all the media partners for the promotion of our event to glory.

Conference Series LLC congratulates the best poster award winner Dr. Valerie Morineaux, Direction générale de l'Armement, France, Mr. Marlon Henrique e Silva Cardoso, Universidade de Brasília, Brazil and Alena Dmitrievna Volyntceva, Lomonosov Moscow State University, Russia. We would also like to thank Dr. Boris Zaslavsky, Cleveland Diagnostics, USA and Dr. Jill Barber, University of Manchester, UK who supported us by evaluating the posters.

We once again thank all the participants for their wonderful contribution towards the event which helped us for successful accomplishment of this event.

Conference Series LLC 7th International Conference & Expo on Proteomics would not have been successful if it has not been supported by international, multi-professional steering committee and coordination of the Journal of Proteomics & Bioinformatics, Journal of Pharmacogenomics & Pharmacoproteomics & Journal of Data Mining in Genomics & Proteomics.

After the successful completion of seven consecutive conferences we are overwhelmed to announce our next upcoming conferences which are going to be held in Europe is the “9th International Conference and Expo on Proteomics” which is going to be held during October 23-25, 2017 in Paris, France.


Past Reports  Proceedings  Gallery  

Proteomics 2015

OMICS International takes a great pride in announcing the “5th International Conference on Proteomics & Bioinformatics (Proteomics-2015) which was held in Valencia, Spain, during 01-03 September, 2015.

Proteomics-2015 witnessed an amalgamation of peerless speakers who enlightened the crowd with their knowledge and confabulated on various newfangled topics related to the field of proteomics and bioinformatics. The extremely illustrious conference hosted by OMICS International was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 25 countries around the world.

The conference aimed a parallel rail with theme “Emerging trends with new innovations in proteomics and bioinformatics”. The meeting engrossed a vicinity of cognizant discussions on novel subjects like Proteomics from Discovery to Function, Mass Spectrometry in Proteome Research, Molecular Modeling & Drug Design, Recent advancements in Proteomics & Bioinformatics, to mention a few. The three days event implanted a firm relation of upcoming strategies in the field of Proteomics, Bioinformatics and Mass Spectrometry Technology with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

The Organizing Committee would like to thank the moderators Dr. Peter Nilsson, KTH-Royal Institute of Technology, Sweden, Dr. Alex Bayes, Biomedical Research Institute Sant Pau, Spain and Dr. Tiziana Bonaldi, European Institute of Oncology, Italy for their contributions which resulted in smooth functioning of the conference.

The conference was embarked with an opening ceremony followed by a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The highlights of the conference were the keynote forum by prominent scientists, Peter Nilsson, KTH-Royal Institute of Technology, Sweden; Ida Pucci Minafra, University of Palermo, Italy; Magnus S Magnusson, University of Iceland, Iceland; Laszlo Takacs, Biosystems International, Hungary; gave their fruitful contributions in the form of highly informative presentations and made the conference a top notch one.

OMICS International is prerogative to thank the Organizing Committee Members, Keynote speakers, Chair and Co-chairs on transcribing the plenary sessions and workshops in a diversified and variegate manner to make this conference an enviable artifact.

OMICS International offers its heartfelt appreciation to the exhibitor Arrayjet, collaborator Bioval who supported the conference in every aspect for the awe-inspiring exhibition at the venue. We also express our sincere thanks to all the media partners for the promotion of our event to glory.

OMICS International congratulates the best poster award winner Dr. Marwa Eltoweissy, University Medicine of Gottingen, Germany and Brenden Van Wyk, University of Saskatchewan, Canada. We would also like to thank Dr. Patricia Sampaio Tavares Veras, Gonçalo Moniz Research Center- FIOCRUZ, Brazil who was our poster evaluator for her support.

We once again thank all the participants for their wonderful contribution towards the event which helped us for successful accomplishment of this event.

OMICS 5th International Conference on Proteomics & Bioinformatics would not have been successful if it has not been supported by international, multi-professional steering committee and coordination of the Journal of Proteomics & Bioinformatics, Journal of Pharmacogenomics & Pharmacoproteomics & Journal of Data Mining in Genomics & Proteomics.

After the successful completion of five consecutive conferences we are overwhelmed to announce our next upcoming conferences which are going to be held in Europe and USA are “7th International Conference and Expo on Proteomics” which is going to be held during October 24-26, 2016 in Rome, Italy, “6th International Conference & Expo on Proteomics” which is going to be held during March 29-31, 2016 Atlanta, USA, “6th International Conference on Bioinformatics” which is going to be held during August 22-23, 2016 Philadelphia, USA, and “7th International Conference on Bioinformatics” which is going to be held during October 24-25, 2016 Rome, Italy.


Past Reports  Proceedings  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date November 26-28, 2018

Speaker Opportunity

Supported By

Journal of Proteomics & Bioinformatics Journal of Pharmacogenomics & Pharmacoproteomics Journal of Data Mining in Genomics & Proteomics Journal of Biomedical Data Mining

All accepted abstracts will be published in respective Conferenceseries International Journals.

Abstracts will be provided with Digital Object Identifier by


Keytopics

  • Algorithmic Proteomics
  • Analytical Biochemistry
  • Analytical Technologies
  • Animal Proteomics
  • Applied Bioinformatics
  • Big Data
  • Biocomputational Genomics
  • Bioinformatics
  • Bioinformatics
  • Biomarkers
  • Biomedical Proteomics
  • Biophysics
  • Bottom Up Proteomics
  • Cancer Functional Genomics
  • Cancer Immunotherapy Discovery
  • Cancer Proteomics
  • Cancer Systems Biology
  • Cellular Medicine
  • Chemical Biology
  • Clinical Proteomics
  • Computational Biologist
  • Computational Genome Biology
  • Computational Molecular Evolution
  • Computational Systems Biology
  • Diagnostics
  • Digital Pathology
  • Disease Diagnostics
  • Drug Development
  • Environmental Proteomics
  • Functional Proteomics
  • Gas Chromatography
  • Genomics
  • High Performance Liquid Chromatography
  • Immune Genomics
  • Immune Proteomics
  • Immuno-oncology
  • Infectious Disease Diagnostics
  • Lipidomics
  • Liquid Chromatography
  • Mass Spectrometry
  • Mass Spectrometry Imaging
  • Mass Spectrometry Ionization Methods
  • Medical Biochemistry
  • Membrane Proteomics
  • Metabolomics
  • Metaproteomics
  • Molecular And Cellular Proteomics
  • Molecular Devices
  • Molecular Diagnostics
  • Molecular Engineering & Microbiology
  • Molecular Imaging
  • Molecular Medicine
  • Molecular Medicine And Diagnostics
  • Molecular Modeling
  • Neuro Proteomics
  • Next Generation Proteomics
  • Pathology
  • Personalized Healthcare
  • Pharmaceutical Biochemistry
  • Pharmaceutical Microbiology
  • Pharmaceutical Protein
  • Physiological Proteomics
  • Plant Proteomics
  • Plasma Proteomics Research
  • Post-translational Modifications
  • Precision Proteomics
  • Protein Analysis
  • Protein Biochemistry
  • Protein Chemistry
  • Protein Expression
  • Protein Structure Prediction
  • Proteomics
  • Proteomics And Cell Signaling
  • Proteomics Database
  • Proteomics Molecular Biology
  • Quantitative Proteomics
  • Single Cell Proteomics
  • Structural Biochemistry
  • Structural Bioinformatics
  • Synapse Proteomics
  • Tandem Mass Spectrometry
  • Targeted Proteomics
  • Top Down Proteomics
  • Transcriptomics
  • Translational Cancer Genomics
  • Translational Medicine
  • Urine Proteomics